Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 7 Similar Profiles
Measles virus
Medicine & Life Sciences
Oncolytic Viruses
Medicine & Life Sciences
Indoleamine-Pyrrole 2,3,-Dioxygenase
Medicine & Life Sciences
Osteosarcoma
Medicine & Life Sciences
Oncolytic Virotherapy
Medicine & Life Sciences
Interferons
Medicine & Life Sciences
Genes
Medicine & Life Sciences
Myoepithelioma
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2016 2022
Neoadjuvant therapy for patients with high risk stage III melanoma
Domingo-Musibay, E. & Holtan, S. G.
6/1/18 → 5/31/21
Project: Research project
Neoadjuvant Therapy
Melanoma
A PHASE 1/2, OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY OFNKTR-262 IN COMBINATION WITH NKTR-214 AND IN COMBINATION WITH NKTR-214 PLUS NIVOLUMABIN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOR MALIGNANCIES
5/1/18 → 5/31/22
Project: Research project
Neoplasms
nivolumab
Single Arm Phase II Study of Ipilimumab and Nivolumab as
Domingo-Musibay, E. & Holtan, S. G.
BIG TEN CANCER RESEARCH CONSORTIUM
12/1/17 → 1/31/21
Project: Research project
Melanoma
Therapeutics
nivolumab
ipilimumab
Tumor-Infiltrating Lymphocytes
Multicenter Studies
Melanoma
Safety
Therapeutics
refractories
radiation
Research Output 2010 2018
1
Citation
(Scopus)
Myoepithelioma of Soft Tissues A Single Institution Retrospective Case Series
Domingo-Musibay, E., Oliveira, A. M., Okuno, S. H., Petersen, I. A., Rose, P. S. & Robinson, S. I., Jan 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 4, p. 357-361 5 p.Research output: Contribution to journal › Article
Myoepithelioma
Radiotherapy
Drug Therapy
Confidence Intervals
Recurrence
5
Citations
(Scopus)
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Domingo-Musibay, E., Murugan, P., Giubellino, A., Sharma, S., Steinberger, D., Yuan, J., Hunt, M. A., Lou, E. & Miller, J. S., Jan 1 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 58.Research output: Contribution to journal › Article
Open Access
Microsatellite Repeats
Carcinoma
Therapeutics
Natural Killer Cells
Immunotherapy
3
Citations
(Scopus)
Endogenous heat-shock protein induction with or without radiofrequency ablation or cryoablation in patients with stage IV melanoma
Domingo-Musibay, E., Heun, J. M., Nevala, W. K., Callstrom, M., Atwell, T., Galanis, E., Erickson, L. A. & Markovic, S. N., Sep 2017, In : Oncologist. 22, 9, p. 1026-e93Research output: Contribution to journal › Article
Open Access
Cryosurgery
Heat-Shock Proteins
Melanoma
Hot Temperature
Cytotoxic T-Lymphocytes
4
Citations
(Scopus)
Gene and virotherapy for hematological malignancies
Domingo-Musibay, E. & Yamamoto, M., Jul 1 2016, In : International Journal of Hematology. 104, 1, p. 29-41 13 p.Research output: Contribution to journal › Review article
Hematologic Neoplasms
Oncolytic Viruses
Genetic Therapy
Viruses
Genes
6
Citations
(Scopus)
Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy
Iankov, I. D., Kurokawa, C. B., D'Assoro, A. B., Ingle, J. N., Domingo-Musibay, E., Allen, C., Crosby, C. M., Nair, A. A., Liu, M. C., Aderca, I., Federspiel, M. J. & Galanis, E., Sep 3 2015, In : Cancer gene therapy. 22, 9, p. 438-444 7 p.Research output: Contribution to journal › Article
Oncolytic Virotherapy
Aurora Kinase A
Measles virus
Measles
Neoplasms